OKT3 Induction Therapy and Cadaveric Renal Transplantation in Black Patients

By Reinitz E.R.   Kaplan M.P.   Sillix D.H.   Lysz K.  

Transplantation Proceedings, Vol. 29, Iss. 8, 1997-12 ,pp. : 3703-3705

Elsevier

Access to resources Recommend Favorite

Cancer risk associated with ATG/OKT3 in renal transplantation - Principles and Practice

By Hibberd A.D.   Trevillian P.R.   Wlodarzcyk J.H.   Gillies A.H.B.   Stein A.M.   Sheil A.G.R.   Disney A.P.S.  

Transplantation Proceedings, Vol. 31, Iss. 1, 1999-02 ,pp. : 1271-1272

Elsevier

Access to resources Recommend Favorite

Low-Dose OKT3 Treatment for Rejection/Induction in Kidney and Kidney-Pancreas Transplantation

By Desai D.M.   Scandling J.D.   Knoppel C.   Dafoe D.C.   Alfrey E.J.  

Transplantation Proceedings, Vol. 30, Iss. 4, 1998-06 ,pp. : 1552-1554

Elsevier

Access to resources Recommend Favorite

No long-term benefit of low-dose OKT3 induction therapy in non to moderately immunized renal allograft recipients

By Bemelman F.J.   Yong S.   Parlevliet K.J.   Surachno S.   Schellekens P.T.A.   ten Berge R.J.M.  

Transplantation Proceedings, Vol. 34, Iss. 8, 2002-12 ,pp. : 3165-3167

Elsevier

Access to resources Recommend Favorite

Low-dose OKT3 is not effective in the treatment of steroid-resistant acute renal allograft rejections

By Lye W.C.   Vathsala A.   Lee W.T.   Leong S.O.  

Transplantation Proceedings, Vol. 30, Iss. 7, 1998-11 ,pp. : 3106-3107

Elsevier

Access to resources Recommend Favorite